Microbiome startup Vedanta eyes large-scale clinical trials - STAT

Microbiome startup Vedanta eyes large-scale clinical trials - STAT

STAT Plus: Startup Spotlight: Vedanta Biosciences eyes large-scale clinical trials for microbiome drugs

By KATE SHERIDAN

ALEX HOGAN/STAT

With a $27 million Christmas gift, Vedanta Biosciences plans to take its decidedly different approach to bacteria-based drugs to the clinic.

READ MORE